| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents note 5 | 31,930 | 51,874 | ||
| Marketable securities note 5 | 16,184 | 3,523 | ||
| Prepaid expenses and other assets | 1,941 | 1,506 | ||
| Total current assets | 50,055 | 56,903 | ||
| Other assets and restricted cash note 5 | 65 | 42 | ||
| Right-of-use assets note 9 | 79 | 93 | ||
| License agreement note 3 and note 4 | 807 | 863 | ||
| Goodwill | 1,034 | 1,034 | ||
| Total assets | 52,040 | 58,935 | ||
| Accounts payable | 1,943 | 1,218 | ||
| Accrued liabilities other | 1,802 | 1,219 | ||
| Accrued clinical liabilities | 850 | 1,970 | ||
| Accrued compensation | 2,429 | 1,563 | ||
| Current contingent consideration note 4 and note 5 | 1,443 | 1,337 | ||
| Current portion of long-term obligations note 9 | 59 | 58 | ||
| Current portion of convertible debt note 5 and note 6 | 1,204 | 1,208 | ||
| Total current liabilities | 9,730 | 8,573 | ||
| Non-current portion of convertible debt note 5 and note 6 | 8,674 | 8,657 | ||
| Non-current contingent consideration note 4 and note 5 | 0 | 0 | ||
| Convertible preferred stock, value-Series BConvertible Preferred Stock | - | 0 | ||
| Long-term obligations note 9 | 21 | 37 | ||
| Convertible preferred stock, value-Series AConvertible Preferred Stock | - | 0 | ||
| Total liabilities | 18,425 | 17,267 | ||
| Common stock, 0.001 par value, 150,000,000 shares authorized, 52,812,488 issued and outstanding at september 30, 2025 and 34,685,072 issued and outstanding at december 31, 2024 | 121 | 118 | ||
| Additional paid-in capital | 279,049 | 272,670 | ||
| Accumulated deficit | -245,564 | -231,123 | ||
| Accumulated other comprehensive income | 9 | 3 | ||
| Total stockholders' equity | 33,615 | 41,668 | ||
| Total liabilities and stockholders' equity | 52,040 | 58,935 | ||
ACHIEVE LIFE SCIENCES, INC. (ACHV)
ACHIEVE LIFE SCIENCES, INC. (ACHV)